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Surgicel Nu-Knit hemostat for bleeding control of
fragile sternum
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Sabine Daebritz, MD, and Bruno Reichart, MD, Munich, Germany
Profuse bleeding from the sternal marrow after sternot-omy is routinely controlled with bone wax because it iseffective, cheap, and therefore favorable. However, bonewax inhibits osseous fusion and promotes infections.1
The increasing numbers of patients with high risk for sternal
instability and wound-healing complications after cardiac surgery
requires improved concepts in bleeding control without the use of
bone wax. We present an alternative technique to control bleeding
from the sternal bone marrow with patches of oxidized regenerated
cellulose (Nu-Knit; Ethicon, Johnson & Johnson, Somerville, NJ).
Technique
A 73-year-old woman with unstable angina was referred to our
department for urgent surgical revascularization and mitral valve
repair. In addition, the patient had insulin-dependent diabetes,
chronic obstructive lung disease, and obesity (body mass index,
32.4).
Median sternotomy revealed a fragile sternum and severe os-
teoporosis with excessive bleeding from the bone marrow. Elec-
trocautery to the periostium was used sparingly to control bleed-
ing, and patches of 3  9–inch Surgicel Nu-Knit hemostat (one 6
 9–inch Surgicel Nu-Knit hemostat cut in half) were placed on
each side of the sternum (Figure 1). Additionally, towels were
wrapped around the absorbable hemostatic patches for their opti-
mal fixation and for atraumatic management of the tissue before
the retractor was inserted. After 2 to 3 minutes, a good hemostatic
effect with the Surgicel Nu-Knit hemostat (Figure 2) was achieved.
Full heparinization (active clotting time  400 seconds) was
initiated for the extracorporeal circulation. Routine coronary arte-
rial bypass grafting (3 grafts) and mitral valve repair were per-
formed. After surgical intervention and decannulation, protamine
was administered to antagonize heparin completely. The hemo-
static patches were removed from the sternum, and no additional
hemostatic agent was administered. Finally, the sternum was
closed in a standard fashion with wires. The wound was closed in
layers, with intracutaneous
sutures used for skin closure.
The intraoperative and post-
operative course of the patient
was uneventful. No enhanced
bleeding, infection, or sternal
wound-healing complication
occurred postoperatively.
To date, we have performed this hemostatic procedure in 53
patients at high risk for unstable sternum and infection. We had
good or at least satisfactory intraoperative blood control in all
cases. We observed no in-hospital mortality. No patient required a
reoperation because of bleeding or unstable sternum. None of the
patients had a deep sternal wound infection.
Discussion
Bone wax should not be used excessively and should be avoided in
patients at high risk for infection or nonunion altogether.1 In
particular, bone wax might not even be effective in elderly patients
and those with osteoporosis. The spongiosa scaffold of the sternum
can be destroyed during setting of bone wax, and the marrow
cavity might absorb large quantities of bone wax with still en-
hanced bleeding. As shown in our case, use of the topical hemo-
static agent Surgicel Nu-Knit is a simple, capable, and effective
method for sternal bleeding control in a high-risk patient.
Our experience with the conventional Surgicel hemostat for
sternal bleeding control has demonstrated safety and practicabil-
ity,2 but it is less efficient than the Surgicel Nu-Knit hemostat. The
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doi:10.1016/j.jtcvs.2005.04.013 Figure 1. Oxidized regenerated cellulose (Surgicel Nu-Knit he-
mostat, 3 9 inches) was placed on both sides of the sternotomy.
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preparation of the oxidized regenerated cellulose as Surgicel Nu-
Knit has triple density, has 150% thickness, and is more tear proof
than the classic Surgicel patch. The enlarged surface matrix pro-
vided an additive hemostatic effect as a result of improved platelet
adhesion. In addition to the hemostatic effect, oxidized regenerated
cellulose has been shown to reduce significantly Staphylococcus
aureus growth in vitro,3 which represents one of the main bacteria
responsible for sternal wound infections. Therefore, a beneficial
bactericidal effect in vivo can be presumed. Oxidized regenerated
cellulose is a fully resorbable topical hemostatic agent, and usually
the Surgicel Nu-Knit patches were removed before sternal wiring.
However, accidentally extant material will be reabsorbed in 3 to 5
weeks.
Other agents, like fibrin sealant4 or microfibrillar collagen,
also have a good hemostatic effect, but they are cost-intensive.
In addition, microfibrillar collagen might cause adverse effects
because the small diameter of its needle-shaped structure po-
tentially passes the filters of blood-saving devices and enters the
patient’s circulation. This might result in organ damage (eg,
lung or brain).5
In conclusion, oxidized regenerated cellulose patches can be
temporarily administered safely and effectively to avoid sternal
bleeding complications with consecutive wound-healing problems
and mediastinitis.
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Figure 2. Towels were wrapped around the hemostatic patches
(black arrow) for optimized fixation and atraumatic management
of the tissue before insertion of the retractor. Full heparinization
(active clotting time > 400 seconds) was initiated.
Brief Communications
606 The Journal of Thoracic and Cardiovascular Surgery ● August 2005
